Captor Therapeutics

Wroclaw, Poland

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

$17.7M raised

Mar 2026

Post-IPO Equity

Biopharma Biotechnology Medical

Top Investors

EIC Accelerator

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Captor Therapeutics

How much funding has Captor Therapeutics raised?

Captor Therapeutics has raised $17.7M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.

Who are Captor Therapeutics's investors?

Captor Therapeutics's investors include EIC Accelerator.

Where is Captor Therapeutics headquartered?

Captor Therapeutics is headquartered in Wroclaw, Poland.

What does Captor Therapeutics do?

Captor Therapeutics is a bio-pharmaceutical firm focused on development of protein degradation drugs for cancer and autoimmune diseases.

What stage is Captor Therapeutics at?

Captor Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 27, 2026.

MLA

"Captor Therapeutics — Funding & Investors." VCBacked, March 27, 2026, https://www.vcbacked.co/company/captor-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2026). Captor Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/captor-therapeutics

Wikipedia (cite web)

{{cite web |title=Captor Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/captor-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 27, 2026.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.